Protalix Biotherapeutics (PLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2007 | 12-2006 | 09-2006 | 06-2006 | 03-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 24,896 | 15,378 | 826 | 925 | 932 |
| Marketable Securities | N/A | 7,577 | N/A | N/A | N/A |
| Receivables | 2,244 | 1,336 | N/A | N/A | N/A |
| TOTAL | $27,140 | $24,291 | $838 | $946 | $961 |
| Non-Current Assets | |||||
| PPE Net | 2,898 | 2,404 | N/A | N/A | N/A |
| Other Non-Current Assets | 320 | 293 | 0 | 0 | 0 |
| TOTAL | $3,218 | $2,697 | $N/A | $N/A | $N/A |
| Total Assets | $30,358 | $26,988 | $838 | $946 | $961 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,230 | 2,268 | 12 | 14 | 0 |
| Accrued Expenses | N/A | N/A | N/A | N/A | 58 |
| TOTAL | $2,230 | $2,268 | $12 | $14 | $58 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 510 | 436 | 0 | 0 | 0 |
| TOTAL | $510 | $436 | $N/A | $N/A | $N/A |
| Total Liabilities | $2,740 | $2,704 | $12 | $14 | $58 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 6,566 | 6,566 | 58 | 58 | 58 |
| Common Shares | 66 | 62 | 1 | 1 | 1 |
| Retained earnings | -23,962 | -20,512 | -3,902 | -3,795 | -3,824 |
| Other shareholders' equity | 0 | 355 | 0 | 0 | 0 |
| TOTAL | $27,618 | $24,284 | $825 | $932 | $903 |
| Total Liabilities And Equity | $30,358 | $26,988 | $838 | $946 | $961 |